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Abstract
Purpose Cancer survivors construct perceptions of illness as a
(mal)adaptive mechanism. These perceptions motivate/drive
subsequent self-management behaviors toward symptoms and
treatment that influence health outcomes. Negative illness per-
ceptions have been associated with increased mortality in oth-
er chronically ill groups. However, this association is under-
researched in cancer survivors. We aimed to explore the asso-
ciation between illness perceptions and mortality in stage I–III
progression-free colorectal cancer (CRC) survivors.
Methods We used data from the population-based Patient
Reported Outcomes Following Initial treatment and Long
Term Evaluation of Survivorship (PROFILES) registry of
two CRC survivorship studies conducted in 2009 and 2010.
We accessed clinical data from the Netherlands Cancer
Registry, and mortality data from municipal personal records
database. Follow-up was until 31 December 2014. Survivors
(n = 1552) completed the Brief Illness Perception
Questionnaire. Cox proportional hazard models estimated
the association between illness perceptions and mortality.
Results Negative illness perceptions on consequences (adjust-
ed hazard ratio (HRadj) 1.60, 95 % confidence interval (CI)
1.14–2.25) and emotion (HRadj 1.65, 95 % CI 1.18–2.31)
were associated with higher mortality, after adjusting for de-
mographic, clinical, and lifestyle factors. Smoking and inade-
quate physical activity were independently associated with
mortality for all Brief Illness Perception Questionnaire
(BIPQ) dimensions.
Conclusions Survivors’ perceptions of their illness are impor-
tant as these perceptions may influence health outcomes dur-
ing survivorship period. Clinical practice needs to identify and
address maladaptive illness perceptions to support more adap-
tive self-management behaviors and enhance survivorship.
Implications for cancer survivors Cancer survivors may ben-
efit from interventions that address potentially maladaptive
perceptions and encourage more adaptive self-management
behaviors.
Keywords Cancer . Illness perceptions .Mortality .
Population-based . Survivors
Introduction
Cancer survivors with similar clinical characteristics can
have vastly different perceptions of and responses to their
illness. These differences, postulated by the Common
Sense Model (CSM) of self-regulation, are due to the
personal model or representation of illness that individuals
construct as a (mal)adaptive mechanism when confronted
with an illness [1]. Representations, cognitive and emo-
tional, can be informed by previous experience,
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observations, or received information of the illness and
related symptoms [2]. These representations or illness per-
ceptions motivate subsequent self-management behaviors
such as lifestyle changes [3, 4] and treatment adherence
[5] that can determine health outcomes. The CSM is a
relevant model for cancer survivorship as it considers in-
dividuals as problem solvers actively involved in the man-
agement of their own health. It implies that maladaptive
cognitions of cancer survivors can be addressed, through
interventions, to achieve better health outcomes when they
have a more adaptive understanding of their condition and
are able to evaluate the effects of acting on this under-
standing [6].
Among cancer survivors, negative illness perceptions have
been associated with poorer self-efficacy to manage cancer- or
treatment-related problems [7], and poorer self-management
behaviors such as passive or maladaptive coping [8, 9], and
poorer treatment adherence [10]. Individuals with negative
perceptions also report poorer health outcomes such as higher
symptom burden [11], psychological distress [12], and lower
quality of life [13]. The association between illness percep-
tions and mortality has been studied in other chronic diseases
such as end-stage renal disease [14] and heart disease [15],
whereby negative illness perceptions were associated with
higher mortality risks. Research into the association between
illness perceptions and mortality among cancer survivors is
scarce. In a study of newly diagnosed breast and non-
metastatic colorectal cancer (CRC) survivors, not believing
in the curability of cancer has been associated with increased
mortality during 15 years of follow-up [16, 17].
Understanding the association of illness perceptions with
mortality among cancer survivors is especially relevant as
these individuals are living longer due to earlier detection
and improved treatments [18]. This trend is also noted in
CRC where survival has improved in recent years [19, 20].
CRC is the third most common cancer, with an annual number
of new cases of approximately 132,000 in the USA [21] and
342,000 in Europe [22]. In the Netherlands, the number of
individuals surviving CRC is projected to increase from 58,
000 in 2009 to approximately 92,000 by 2020, of which
>50 % are considered long-term survivors (≥5 years post-di-
agnosis) [23]. This rapidly growing group is expected to self-
manage late- and long-term effects of CRC and its treatment
whose self-management strategies may be influenced by ill-
ness perception [24]. Emerging results indicate a link between
self-management activities on lifestyle factors and CRC sur-
vival [25, 26].
Our study aimed to explore the association of illness per-
ceptions with mortality in progression-free CRC survivors
diagnosed within 5 years of survey and treated with curative
intent.We hypothesize that CRC survivors with more negative
illness perceptions will have higher mortality risk compared
with survivors with more positive illness perceptions.
Methods
Setting and participants
For this study, we included individuals diagnosed with stage
I–III CRC between 2004 and 2009 in South Netherlands as
registered in the Netherlands Cancer Registry (NCR). The
NCR records data on all individuals who are newly diagnosed
with cancer in the southern part of the Netherlands. Exclusion
criteria included cognitive impairment, had died prior to start
of the study (according to the Central Bureau for Genealogy
which collects information on all deceased Dutch citizens via
the civil municipal registries, and hospital records) or had
unverifiable addresses. For a complete overview of sample
selection process, please refer to the Patient Reported
Outcomes Following Initial treatment and Long Term
Evaluation of Survivorship (PROFILES) registry website un-
der “data & documentation” (http://www.profilesregistry.nl/
dataarchive/study_units/view/22).
Ethical approval for the study was obtained from a local
certified Medical Ethics Committee of the Maxima Medical
Centre Veldhoven, Netherlands.
Data collection
This secondary study pooled data from two separate surveys
on CRC survivors conducted in January 2009 and December
2010 to evaluate patient-reported outcomes. Details of these
studies are reported elsewhere [27]. Data collection was com-
pleted within PROFILES registry as previously described
[28]. In short, eligible survivors invited to participate in the
study were given the option of completing either an online or
paper questionnaire. Survivors were reassured that non-
participation had no consequences on their follow-up care or
treatment. All participants provided informed consent. Non-
respondents were sent a reminder letter and questionnaire
within 2 months. Data from PROFILES is linked directly to
clinical data from the NCR and is readily available for re-




Respondents completed the Dutch version of the Brief Illness
Perception Questionnaire (BIPQ) [29] at time of survey. The
BIPQ has sound psychometric properties and has been used
with cancer populations (www.uib.no/ipq) [30]. The BIPQ
consists of eight items: Five items assess cognitive
representations (consequences, timeline, personal control,
treatment control, identity), two items assess emotional
representations (concern, emotion), and one item assesses
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illness comprehensibility (coherence). It uses a single-item
scale approach to assess perceptions on a linear 1–10 point
scale. The responses of three items (personal control, treat-
ment control, coherence) were recorded to be in the same
direction as the other items for statistical analyses. Higher
scores indicated more negative perceptions.
Demographics, clinical, and lifestyle data
Self-reported demographic data included marital status and
education level. Comorbid status at the time of survey was
categorized according to the adapted Self-Administered
Comorbidity Questionnaire (SCQ) [31].
Survivors’ demographics and clinical information includ-
ing date of birth, date of diagnosis, clinical stage according to
the tumor–node–metastasis clinical classification [32], and
treatment were accessed from the NCR.
Lifestyle factors included self-reported smoking, alcohol
use, body mass index (BMI), and physical activity. BMI was
calculated with self-reported height and weight. On the vali-
dated European Prospective Investigation into Cancer (EPIC)
Physical Activity Questionnaire [33], survivors reported the
average time spent, during winter and summer, on walking,
cycling, gardening, household activities, and sports. Hours per
week spent on moderate-to-vigorous physical activity
(MVPA) were derived from estimated metabolic equivalent
intensity values assigned to each activity based on previously
described classifications [34, 35].
Disease progression
Data of metachronous metastases occurring between initial
cancer diagnosis and time of survey were retrospectively re-
trieved from medical files [36].
Statistical analyses
We had previously found that CRC survivors with metastatic
disease had significantly more negative illness perceptions
than survivors with non-metastatic disease [37]. Therefore,
to assess the relative risk of illness perceptions and mortality,
we included only survivors with no metachronous metastasis
at time of survey in our analyses. To facilitate interpretation of
results in daily clinical practice and to identify the survivors
with the most negative illness perception, we dichotomized
the BIPQ scores using the 75th interquartile range score as
cutoff, as previously done [38].
To determine the prevalence of survivors who scored neg-
atively on multiple BIPQ dimensions, we derived two scale
scores from the dichotomized BIPQ scores: cognitive and
emotional representation. We summed the BIPQ dimensions
categorized as negative for each subscale: cognitive represen-
tation (consequences, timeline, personal control, treatment
control, identity) and emotional representation (concern, emo-
tion). Differences in demographic and clinical characteristics,
and lifestyle factors between respondents with negative (e.g.,
the top 10 % of patients) and positive representations were
assessed using independent sample t test or Mann–Whitney
test, and chi-square test, where appropriate.
Cox proportional hazard models were used to estimate the
associations between BIPQ dimensions and mortality.
Confounders for adjustment in the Cox models were selected
a priori. These included age at survey, sex, education, marital
status, comorbidity, cancer type, cancer stage, smoking, alco-
hol consumption, and physical activity. As survivors were
assessed 1–5 years after cancer diagnosis, the Cox models
were left-truncated and the time of questionnaire completion
was set as entry time to minimize survivorship bias. Time
since cancer diagnosis was used as the underlying time scale
for the Cox regression. Follow-up time was calculated from
cancer diagnosis until death or end of follow-up on 31
Dec 2014, whichever occurred first.
All tests were two-sided and significant if p < 0.05.
Descriptive analyses were performed using Statistical
Package for Social Sciences (SPSS, Chicago, IL, USA) ver-
sion 22 for Windows, and Cox regression analyses were per-




In total, 2229 (70 %) survivors responded. Differences in
characteristics among respondents, non-respondents, and pa-
tients with non-verifiable addresses have been reported else-
where [27]. Of the respondents, 6 had emigrated before end of
follow-up, 9 had survey dates that occurred before start of
study, 457 were not reviewed for metachronous metastases,
135 had metachronous metastasis at time of survey, and 70 did
not complete any BIPQ dimensions. These respondents were
excluded in the analyses, resulting in a final sample of 1552
survivors.
Illness perceptions
The median and 75th interquartile BIPQ scores for the sample
are shown in Table 1. The percentage of survivors who scored
negatively on the BIPQ dimensions ranged between 20 and
23 %.
On the prevalence of survivors with negative perceptions
on multiple BIPQ items, 12 % scored negatively on at least
three of the five cognitive BIPQ dimensions and 13 % scored
negatively on both emotional BIPQ dimensions. Survivors
with negative cognitive representations were more likely to
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have rectal cancer, treated with surgery and radiotherapy, and
have high education level, and less likely to meet the Dutch
physical activity guidelines (Table 2). For negative emotional
representations, significant differences were found for time
since diagnosis and BMI, whereby shorter time since diagno-
sis and higher BMI were associated with negative emotional
representations. Survivors with negative cognitive or emo-
tional representations were more likely to have two or more
comorbid conditions than survivors with positive representa-
tions. However, significant differences in prevalence of heart
conditions, diabetes mellitus, and osteoarthritis were noted
only among survivors with negative cognitive representations.
Current drinkers were more likely to have positive cognitive
or emotional representations.
Illness perceptions and mortality
As of 31 December 2014, 249 (16 %) respondents had died.
The mean time from survey completion to end of follow-up
was 4.4±1.3 years.
In the unadjusted Cox model, negative perceptions on con-
sequences, timeline, identity, and emotion were associated
with higher mortality risks (Table 3, model 1). Following full
adjustment of demographic, clinical, and lifestyle variables
(Table 3, model 4), negative perceptions on consequences
(adjusted hazard ratio (HRadj) 1.60, 95 % confidence interval
(CI) 1.14–2.25) and emotion (HRadj 1.65, 95 % CI 1.18–2.31)
remained significantly associated with higher mortality risks.
Lifestyle factors such as smoking and physical activity were
independently associated with mortality for all BIPQ dimen-
sions. The adjusted hazard estimates of being a current smoker
ranged between 2.32 and 2.46 (data not shown). Survivors
who meet the Dutch guidelines for physical activity per week
had approximately 4 % reduced risk of mortality (data not
shown).
Discussion
In this large population-based study of stage I–III
progression-free CRC survivors, approximately one fifth
of respondents had negative illness perceptions. Negative
perceptions on consequences and emotions remained asso-
ciated with higher risk of mortality, after adjusting for a
range of demographic, clinical, and lifestyle variables.
These results are in line with previous research which re-
ported that newly diagnosed CRC survivors with negative
belief in the curability of cancer had higher mortality risks
in 15 years of follow-up [17].
In our study, negative perceptions on consequences and
emotions remained significant predictors of mortality, even
after extensive adjustments of possible confounders.
Perceptions of more negative consequences has been shown
to be one of the strongest predictors of poorer health outcomes
and slower return to work in a range of chronic illness includ-
ing cancer [30]. Cancer survivors on chemotherapy who attri-
bute their symptom burden as negative consequences of their
illness experienced more psychological distress [11].
Similarly, negative emotion was associated with higher mor-
tality. Studies suggest that stress-related adaption processes
could have physiological consequences such as alterations in
cellular immune function and pro-inflammatory signaling dur-
ing cancer survivorship which in turn could influence disease
progression [39].
Table 1 Brief Illness Perception Questionnaire (BIPQ) dimension scores of stage I–III progression-free CRC survivors (n = 1552)








BIPQ1: consequences How much does your illness affect your life? (1: no affect; 10: severely affects) 8 3 (6) 311 (20)
BIPQ2: timeline How long do you think your illness will continue? (1: very short time; 10: forever) 81 3 (7) 325 (21)
BIPQ3: personal
control
How much control do you feel you have over your illness? (1: extreme control;
10: absolutely no control)
53 6 (9) 338 (22)
BIPQ4: treatment
control
How much do you think your treatment can help your illness? (1: extremely;
10: not at all)
95 4 (5) 327 (21)
BIPQ5: identity How much do you experience symptoms from your illness? (1: no symptoms at all;
10: many severe symptoms)
40 3 (5) 351 (23)
BIPQ6: concern How concerned are you about your illness? (1: not concerned; 10: extremely concerned) 30 4 (6) 313 (20)
BIPQ7: coherence How well do you feel you understand your illness? (1: understand clearly;
10: do not understand)
46 3 (6) 313 (20)
BIPQ8: emotion How much does your illness affect you emotionally? (1: not at all; 10: extremely) 36 3 (5) 338 (22)
a The 75th interquartile score (IQS) was used as the cutoff, whereby higher score indicates negative perceptions
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Table 2 Demographic and
clinical characteristics of stage
I–III progression-free CRC
survivors (n= 1552), stratified by
cognitive and emotional
representations as measured with
the Brief Illness Perception
Questionnaire (BIPQ)










Male 106 (57) 772 (57) 0.8 102 (52) 776 (57) 0.2
Mean age at survey + SD 68.4 ± 10.5 69.6 ± 9.4 0.1 68.1 ± 9.6 69.6 ± 9.6 0.03
Mean years since initial
diagnosis ± SD
2.9 ± 0.9 2.9 ± 1.0 0.5 2.8 ± 1.0 2.9 ± 1.0 0.02
Type of cancer <.0001 0.1
Colon 97 (52) 923 (68) 118 (67) 902 (67)
Rectal 88 (48) 444 (33) 77 (40) 455 (34)
Cancer stage 0.8 0.8
I 61 (33) 424 (31) 60 (31) 425 (31)
II 70 (38) 549 (40) 81 (42) 538 (40)
III 54 (29) 394 (29) 54 (28) 394 (29)
Primary treatment <.0001 0.1
SU 75 (41) 731 (54) 90 (46) 716 (53)
SU+RT 65 (35) 276 (20) 56 (29) 285 (21)
SU+CT 31 (17) 288 (21) 39 (20) 280 (21)
SU+RT+CT 14 (8) 72 (5) 10 (5) 76 (6)
No. of self-reported comorbid
conditions
<.0001 0.001
None 38 (21) 431 (32) 45 (23) 424 (31)
One 37 (20) 399 (29) 45 (23) 391 (29)
Two or more 110 (60) 537 (39) 105 (54) 542 (40)
Prevalent comorbid conditions
Heart condition 42 (26) 224 (19) 0.04 40 (24) 226 (19) 0.1
High blood pressure 75 (47) 429 (36) 0.01 70 (42) 434 (37) 0.1
Diabetes mellitus 37 (24) 179 (16) 0.01 29 (18) 187 (16) 0.5
Osteoarthritis 59 (38) 335 (29) 0.03 57 (35) 337 (30) 0.1
In partnered relationship 131 (71) 1033 (76) 0.1 144 (74) 1020 (75) 0.7
Socioeconomic status 0.6 0.3
Low 39 (22) 310 (23) 45 (24) 304 (23)
Medium 70 (40) 535 (41) 83 (45) 522 (40)
High 60 (35) 457 (35) 55 (30) 462 (35)
Education level 0.03 0.7
Low 27 (15) 258 (19) 39 (20) 246 (19)
Medium 103 (57) 809 (60) 117 (60) 795 (60)
High 51 (28) 272 (20) 38 (20) 285 (22)
Body mass index 27.2 ± 5.0 26.8 ± 4.3 0.3 27.6 ± 5.1 26.7 ± 4.3 0.03
Current smoker 27 (15) 149 (11) 0.1 25 (14) 151 (11) 0.3
Current alcohol drinker 85 (57) 734 (66) 0.02 83 (54) 736 (66) 0.003
Moderate-to-vigorous physical
activity (hours/week)
8.6 ± 7.7 11.0 ± 8.9 <.0001 10.2 ± 8.5 10.8 ± 8.9 0.3
Percentages may not add up to 100 % due to rounding up of decimals
a Cognitive representation scale: consequences, timeline, personal control, treatment control, and identity.
Negative cognitive representation: scored negatively in at least three of the five dichotomized cognitive BIPQ
dimensions
b Emotional representation scale: concern and emotion. Negative emotional representation: scored negatively on
two out of two dichotomized emotional BIPQ representations
Percentages may not add up to 100 % due to rounding up of decimals
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The strong association between illness perceptions and
mortality risk among the chronically ill attests to the im-
portance of cognitive and behavioural adaptation to chron-
ic illness. Among cancer survivors, negative perceptions
have been associated with poorer self-efficacy [7] and
poorer self-management behaviors such as passive coping
[8]. Pre-treatment negative illness perceptions have been
associated with maladaptive coping such as venting, sub-
stance use, and denial in head and neck cancer survivors
[9]. Negative perceptions about treatment efficacy can also
influence adherence to treatment recommendations [10]. In
our study, a significant proportion of survivors (21 %) per-
ceived their treatment as being not helpful. These negative
perceptions could influence subsequent self-management
behaviors. We found that survivors with negative cognitive
representations were physically less active, probably as
they also had more comorbidity. Insufficient physical ac-
tivity and being a current smoker were independent risk
factors of mortality in all BIPQ dimensions (data not
shown). This is in line with previous research of a link
between lifestyle factors and CRC survival [25, 26].
These points taken together highlight the need for interven-
tion to address possible maladaptive perceptions and im-
prove survivors’ self-management strategies for a healthier
survivorship and better clinical outcome. Such intervention
is especially salient for CRC survivors as they tend to be
older. Older cancer survivors have been found to be less
aware of the benefits of lifestyle changes for better health
outcomes [40].
Our results contribute to the growing body of research that
negative illness perceptions are a significant risk factor for
mortality that clinicians need to address [16, 17]. In contrast
to other significant risk factors such as age, comorbidity, or
cancer stage (data not shown), maladaptive illness perceptions
have shown to be amenable to psycho-educational interven-
tions in other cancer populations. A physical activity interven-
tion to address shoulder morbidity among breast cancer survi-
vors reduced perceptions of symptom severity and perceived
consequences [41]. Positive changes in illness perceptions
improved emotional well-being among breast cancer survi-
vors who attended a psychosocial aftercare program [42]. A
cognitive-behavioral stress management intervention
targeting negative affect and cognitions was shown to down-
regulate anxiety-related pro-inflammatory and metastasis-
related gene expression in circulating leukocytes in early stage
breast cancer survivors [43].
Our study has limitations. The years from survey comple-
tion until end of follow-up is relatively short. Our sample
consisted of a cross section of CRC survivors with varying
years since initial CRC diagnosis. Therefore, it is plausible




Deaths Model 1 (unadjusted);
HR (95 % CI)
Model 2 (Model
1 + demographics);
HR (95 % CI)
Model 3 (Model
2 + clinical);
HR (95 % CI)
Model 4 (Model
3 + lifestyle);
HR (95 % CI)
BIPQ1 - consequences + 184/1233 ref ref ref ref
− 64/311 1.47 (1.11-1.96) 1.66 (1.23-2.23) 1.62 (1.21-2.18) 1.60 (1.14-2.25)
BIPQ2 - timeline + 166/1146 ref ref ref ref
− 69/325 1.57 (1.19-2.08) 1.43 (1.07-1.91) 1.44 (1.07-1.93) 1.32 (0.94-1.86)
BIPQ3 - personal control + 185/1161 ref ref ref ref
− 54/338 0.96 (0.71-1.30) 0.91 (0.67-1.24) 0.93 (0.68-1.27) 1.00 (0.70-1.42)
BIPQ4 - treatment control + 168/1135 ref ref ref ref
− 62/327 1.30 (0.97-1.74) 1.15 (0.85-1.55) 1.16 (0.86-1.57) 1.13 (0.80-1.58)
BIPQ5 - identity + 172/1161 ref ref ref ref
− 68/351 1.34 (1.01-1.77) 1.54 (1.15-2.05) 1.51 (1.13-2.02) 1.31 (0.92-1.85)
BIPQ6 - concern + 184/1209 ref ref ref ref
− 56/313 1.25 (0.93-1.69) 1.47 (1.09-2.00) 1.48 (1.09-2.01) 1.35 (0.94-1.92)
BIPQ7 - coherence + 179/1193 ref ref ref ref
− 57/313 1.18 (0.88-1.59) 1.25 (0.93-1.69) 1.25 (0.92-1.69) 1.07 (0.75-1.52)
BIPQ8 – emotion + 171/1178 ref ref ref ref
− 66/338 1.38 (1.04-1.84) 1.67 (1.25-2.24) 1.63 (1.22-2.19) 1.65 (1.18-2.31)
Demographics: age at survey, gender, relationship status, and education level; clinical: type of cancer, stage of cancer, and comorbid conditions; lifestyle:
BMI, smoking, alcohol consumption, and physical activity
HR hazard ratio, CI confidence interval
a BIPQ: Brief Illness Perception Questionnaire. The 75th interquartile score was used as the cutoff, whereby higher score indicates negative perceptions
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that shorter-term survivors, compared with longer-term survi-
vors, report more negative illness perceptions. We addressed
possible survivorship bias by using a left-truncated Cox re-
gressionmodel.We could not confirm the metastasis status for
a proportion of respondents. Mortality estimates should be
interpreted with caution as exclusion of these respondents
could have biased the results. Although we have corrected
for a range of factors, there is a possibility of residual con-
founding. For example, we did not explicitly assess self-
management strategies. Nevertheless, our study is one of the
first to assess the mortality risks associated with illness per-
ceptions in a large population-based CRC sample with a high
response rate.
In conclusion, our study adds to the growing body of re-
search highlighting the importance of assessing survivors’
perceptions of their illness as these can influence health out-
comes during survivorship period. Research shows that illness
perceptions are amenable to intervention. It is therefore im-
portant to address potentially maladaptive perceptions and
encourage more adaptive self-management behaviors among
CRC survivors treated curatively to ensure that they achieve
better health outcomes during survivorship.
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